• Epilepsy
  • Multiple Sclerosis
  • Movement Disorders
  • Dementia and Alzheimer Disease
  • Neuromuscular
  • Stroke
  • Headache and Migraine
  • Sleep Disorders

Latest News

Bridging the Gap, De-Escalation of MS Disease Modifying Therapies: Carolyn H Goldschmidt, DO
Bridging the Gap, De-Escalation of MS Disease Modifying Therapies: Carolyn H Goldschmidt, DO

June 6th 2023

Carolyn H. Goldschmidt, DO, a neurologist at NorthShore University Health System in Chicago, talked about a retrospective study analyzing disease-modifying therapies in multiple sclerosis patients at CMSC 2023.

Biogen and Denali Terminate Phase 3 LIGHTHOUSE Study of BIIB122 in LRRK2-related Parkinson Disease
Biogen and Denali Terminate Phase 3 LIGHTHOUSE Study of BIIB122 in LRRK2-related Parkinson Disease

June 6th 2023

Pimavanserin Tolerable in PSTD-Associated Insomnia, Pilot Study Suggests
Pimavanserin Tolerable in PSTD-Associated Insomnia, Pilot Study Suggests

June 6th 2023

Stress Management Protocol Reduces Depression and Anxiety in Patients With MS: Amy Sullivan, MD
Stress Management Protocol Reduces Depression and Anxiety in Patients With MS: Amy Sullivan, MD

June 6th 2023

Effectiveness of Mindfulness-Based Interventions to Reduce Stress in Patients With MS
Effectiveness of Mindfulness-Based Interventions to Reduce Stress in Patients With MS

June 5th 2023

CMSC 2023
SLEEP 2023
Mind Moments podcast
NeuroVoices
EEGTalk with Fabio Nascimento, MD, and Brandon Westover, MD, PhD
Gold Standard Centers
Brain Games
Medical World News

Conference Coverage

View All
Bridging the Gap, De-Escalation of MS Disease Modifying Therapies: Carolyn H Goldschmidt, DO
Bridging the Gap, De-Escalation of MS Disease Modifying Therapies: Carolyn H Goldschmidt, DO

June 6th 2023

Investigating the Impact of a Low-Fat Diet on Quality of Life and Symptom Management in MS: Vijayshree Yadav, MD, MCR, FANA, FAAN
Investigating the Impact of a Low-Fat Diet on Quality of Life and Symptom Management in MS: Vijayshree Yadav, MD, MCR, FANA, FAAN

June 6th 2023

Pimavanserin Tolerable in PSTD-Associated Insomnia, Pilot Study Suggests
Pimavanserin Tolerable in PSTD-Associated Insomnia, Pilot Study Suggests

June 6th 2023

Need for Additional Treatments to Target Secondary Symptoms of Narcolepsy: Anne Marie Morse, DO, FAASM
Need for Additional Treatments to Target Secondary Symptoms of Narcolepsy: Anne Marie Morse, DO, FAASM

June 6th 2023

Video Series
Video Interviews
Podcasts

Most Recent

© 2023 MJH Life Sciences

All rights reserved.